Brief: Adaptive Biotechnologies Reports Fourth Quarter And Full Year 2021 Financial Results
Feb 15 (Reuters) - Adaptive Biotechnologies Corp ADPT.O :
* ADAPTIVE BIOTECHNOLOGIES REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL
RESULTS
* Q4 REVENUE ROSE 26 PERCENT TO $37.9 MILLION
* QTRLY LOSS PER SHARE $0.43
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WAS $570.2 MILLION AS OF
DEC
31, 2021
* Q4 EARNINGS PER SHARE VIEW $-0.45, REVENUE VIEW $36.7 MILLION -- REFINITIV
IBES
DATA
Source text for Eikon: ID:nGNXbDG9PT
Further company coverage: ADPT.O
Recent news on Adaptive Biotechnologies
See all newsAdvisory: Alert incorrectly tagged to Adaptive Biotechnologies withdrawn
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Adaptive Biotechnologies Q2 revenue rises 22%, beats estimates